Bottom line
JIRE vs SWISX: the short answer
JIRE (JPMorgan International Research Enhanced Equity ETF) and SWISX (Schwab International Index Fund) share a meaningful slice of their top holdings — about 58% by weight.
But SWISX is far broader, holding 697 positions to 214 for JIRE, so beyond the top names it adds exposure JIRE doesn't have.
SWISX is cheaper at 0.06% vs 0.24% — a difference of $18 a year per $10,000 invested.
Over five years, JIRE returned +9.7% a year vs +9.0% for SWISX.
Updated Nov 19, 2026
JIRE vs SWISX side by side
| JIRE | SWISX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | J.P. Morgan | Schwab |
| Category | International Stock | International Stock |
| Expense ratio | 0.24% | 0.06% |
| Annual cost per $10k | $24 | $6 |
| 10-yr cost on $10k (prospectus) | $363 | $77 |
| Max front load | None | — |
| 12b-1 fee | — | — |
| 1-yr return | +32.1% | +31.6% |
| 5-yr return (annualized) | +9.7% | +9.0% |
| 10-yr return (annualized) | +8.2% | +8.3% |
| Best quarter | +17.8% | +18.2% |
| Worst quarter | −23.4% | −23.2% |
| Net assets (fund) | $11.2B | $13.6B |
| Number of holdings | 214 | 697 |
| Portfolio turnover | 25% | 1% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JIRE | SWISX | Difference |
|---|---|---|---|
| 2025 | +32.1% | +31.6% | +0.6% |
| 2024 | +3.0% | +3.5% | −0.6% |
| 2023 | +19.7% | +18.2% | +1.5% |
| 2022 | −13.7% | −14.3% | +0.6% |
| 2021 | +12.9% | +11.3% | +1.6% |
| 2020 | +5.4% | +8.1% | −2.7% |
| 2019 | +22.0% | +21.9% | +0.1% |
| 2018 | −14.7% | −13.3% | −1.3% |
| 2017 | +23.3% | +25.3% | −2.0% |
| 2016 | +2.1% | +1.1% | +1.0% |
Source: Fund prospectus bar charts
Holdings overlap
15 of JIRE's top 25 holdings also appear in SWISX's top 25.
| Holding | JIRE | SWISX |
|---|---|---|
| ASML Holding NV | 3.48% | 2.58% |
| Siemens AG | 1.78% | 1.06% |
| AstraZeneca plc | 1.69% | 1.34% |
| Shell plc | 1.55% | 1.03% |
| HSBC Holdings plc | 1.54% | 1.41% |
| Allianz SE | 1.51% | 0.79% |
| Banco Santander SA | 1.36% | 0.88% |
| Nestle SA | 1.33% | 1.14% |
| Roche Holding AG | 1.32% | 1.48% |
| Novartis AG | 1.22% | 1.30% |
| BHP Group Ltd. | 1.16% | 0.81% |
| Toyota Motor Corp. | 1.12% | 0.99% |
| Iberdrola SA | 1.09% | 0.66% |
| Hitachi Ltd. | 1.04% | 0.73% |
| UBS Group AG | 0.97% | 0.70% |
Source: SEC Form N-PORT
JIRE top 10
- ASML Holding NV — 3.48%
- Siemens AG — 1.78%
- AstraZeneca plc — 1.69%
- Shell plc — 1.55%
- HSBC Holdings plc — 1.54%
- Allianz SE — 1.51%
- Banco Santander SA — 1.36%
- UniCredit SpA — 1.33%
- Nestle SA — 1.33%
- Roche Holding AG — 1.32%
SWISX top 10
- ASML Holding NV — 2.58%
- Roche Holding AG — 1.48%
- HSBC Holdings PLC — 1.41%
- AstraZeneca PLC — 1.34%
- Novartis AG — 1.30%
- Nestle SA — 1.14%
- Siemens AG — 1.06%
- Shell PLC — 1.03%
- Toyota Motor Corp — 0.99%
- Sap Se — 0.96%
FAQ
What is the difference between JIRE and SWISX?
Which is cheaper, JIRE or SWISX?
Should I own both JIRE and SWISX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.